For years after it was administered, growth hormone continued to reduce the risk of fractures and helped maintain bone density in postmenopausal women who had osteoporosis, according to a new study. Osteoporosis is a progressive condition that causes the bones to become weak and more likely to break. More than 80% of the people being treated for the condition nationwide are women, according to the Endocrine Society's Facts and Figures Report.
Women are three times more likely to experience an osteoporosis-related bone fracture in their lifetimes than men. "Our study is the largest and longest controlled study of growth hormone treatment for osteoporosis in postmenopausal women to date," said one of the study's authors, Emily Krantz, MD, of Sweden. "Years after treatment stopped, women who were treated with growth hormone still experienced improved bone density and reduced fracture…
